Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 198
Filter
1.
Clin Exp Allergy ; 42(7): 1104-18, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22702509

ABSTRACT

BACKGROUND: The risks for infants and young children receiving inhaled corticosteroid (ICS) therapy are largely unknown. Recent clinical studies indicate that ICS therapy in pre-school children with symptoms of asthma result in decreased symptoms without influencing the clinical disease course, but potentially affect postnatal growth and development. The current study employs a primate experimental model to identify the risks posed by ICS therapy. OBJECTIVE: To (1) establish whether ICS therapy in developing primate lungs reverses pulmonary pathobiology associated with allergic airway disease (AAD) and (2) define the impact of ICS on postnatal lung growth and development in primates. METHODS: Infant rhesus monkeys were exposed, from 1 through 6 months, to filtered air (FA) with house dust mite allergen and ozone using a protocol that produces AAD (AAD monkeys), or to FA alone (Control monkeys). From three through 6 months, the monkeys were treated daily with ICS (budesonide) or saline. RESULTS: Several AAD manifestations (airflow restrictions, lavage eosinophilia, basement membrane zone thickening, epithelial mucin composition) were reduced with ICS treatment, without adverse effects on body growth or adrenal function; however, airway branching abnormalities and intraepithelial innervation were not reduced. In addition, several indicators of postnatal lung growth and differentiation: vital capacity, inspiratory capacity, compliance, non-parenchymal lung volume and alveolarization, were increased in both AAD and Control monkeys that received ICS treatment. CONCLUSIONS AND CLINICAL RELEVANCE: Incomplete prevention of pathobiological changes in the airways and disruption of postnatal growth and differentiation of airways and lung parenchyma in response to ICS pose risks for developing primate lungs. These responses also represent two mechanisms that could compromise ICS therapy's ability to alter clinical disease course in young children.


Subject(s)
Adrenal Cortex Hormones/pharmacology , Allergens/toxicity , Antigens, Dermatophagoides/toxicity , Asthma , Lung , Animals , Asthma/chemically induced , Asthma/drug therapy , Asthma/pathology , Asthma/physiopathology , Child , Child, Preschool , Disease Models, Animal , Female , Humans , Infant , Infant, Newborn , Lung/growth & development , Lung/pathology , Lung/physiopathology , Macaca mulatta , Male
2.
Toxicol Appl Pharmacol ; 213(1): 74-85, 2006 May 15.
Article in English | MEDLINE | ID: mdl-16226776

ABSTRACT

Increases in Clara cell abundance or cellular expression of Clara cell secretory protein (CCSP) may cause increased tolerance of the lung to acute oxidant injury by repeated exposure to ozone (O3). This study defines how disruption of the gene for CCSP synthesis affects the susceptibility of tracheobronchial epithelium to acute oxidant injury. Mice homozygous for a null allele of the CCSP gene (CCSP-/-) and wild type (CCSP+/+) littermates were exposed to ozone (0.2 ppm, 8 h; 1 ppm, 8 h) or filtered air. Injury was evaluated by light and scanning electron microscopy, and the abundance of necrotic, ciliated, and nonciliated cells was estimated by morphometry. Proximal and midlevel intrapulmonary airways and terminal bronchioles were evaluated. There was no difference in airway epithelial composition between CCSP+/+ and CCSP-/- mice exposed to filtered air, and exposure to 0.2 ppm ozone caused little injury to the epithelium of both CCSP+/+ and CCSP-/- mice. After exposure to 1.0 ppm ozone, CCSP-/- mice suffered from a greater degree of epithelial injury throughout the airways compared to CCSP+/+ mice. CCSP-/- mice had both ciliated and nonciliated cell injury. Furthermore, lack of CCSP was associated with a shift in airway injury to include proximal airway generations. Therefore, we conclude that CCSP modulates the susceptibility of the epithelium to oxidant-induced injury. Whether this is due to the presence of CCSP on the acellular lining layer surface and/or its intracellular distribution in the secretory cell population needs to be defined.


Subject(s)
Bronchi/drug effects , Ozone/toxicity , Trachea/drug effects , Uteroglobin/genetics , Animals , Bronchi/pathology , Mice , Mice, Knockout , Mice, Transgenic , Respiratory Mucosa/drug effects , Respiratory Mucosa/pathology , Trachea/pathology
3.
Clin Exp Allergy ; 35(7): 894-906, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16008676

ABSTRACT

BACKGROUND: Accumulation of immune cell populations and their cytokine products within tracheobronchial airways contributes to the pathogenesis of allergic asthma. It has been postulated that peripheral regions of the lung play a more significant role than proximal airways with regard to inflammatory events and airflow obstruction. OBJECTIVE: To determine whether immune cell populations and associated cytokines are uniformly distributed throughout the conducting airway tree in a non-human primate model of allergic asthma. METHODS: We used a stereologic approach with a stratified sampling scheme to measure the volume density of immune cells within the epithelium and interstitium of trachea and 4-5 intrapulmonary airway generations from house dust mite (HDM) (Dermatophagoides farinae)-challenged adult monkeys. In conjunction with immune cell distribution profiles, mRNA levels for 21 cytokines/chemokines and three chemokine receptors were evaluated at four different airway generations from microdissected lungs. RESULTS: In HDM-challenged monkeys, the volume of CD1a+ dendritic cells, CD4+ T helper lymphocytes, CD25+ cells, IgE+ cells, eosinophils, and proliferating cells were significantly increased within airways. All five immune cell types accumulated within airways in unique patterns of distribution, suggesting compartmentalized responses with regard to trafficking. Although cytokine mRNA levels were elevated throughout the conducting airway tree of HDM-challenged animals, the distal airways (terminal and respiratory bronchioles) exhibited the most pronounced up-regulation. CONCLUSION: These findings demonstrate that key effector immune cell populations and cytokines associated with asthma differentially accumulate within distinct regions and compartments of tracheobronchial airways from allergen-challenged primates.


Subject(s)
Asthma/immunology , Cytokines/analysis , Respiratory System/immunology , Animals , Antigens, CD1/immunology , Antigens, Dermatophagoides/immunology , CD4-Positive T-Lymphocytes/immunology , Chemokines/analysis , Dendritic Cells/immunology , Disease Models, Animal , Eosinophils/immunology , Female , Immunoglobulin E/immunology , Immunohistochemistry/methods , Macaca mulatta , RNA, Messenger/analysis , Receptors, Chemokine/analysis , Receptors, Interleukin-2/immunology , Respiratory System/pathology
4.
J Biochem Mol Toxicol ; 19(1): 42-51, 2005.
Article in English | MEDLINE | ID: mdl-15736154

ABSTRACT

Naphthalene is metabolized in the lung and liver to reactive intermediates by cytochrome P450 enzymes. These reactive species deplete glutathione, covalently bind to proteins, and cause necrosis in Clara cells of the lung. The importance of glutathione loss in naphthalene toxicity was investigated by using the glutathione prodrugs (glutathione monoethylester or cysteine-glutathione mixed disulfide) to maintain glutathione pools during naphthalene exposure. Mice given a single intraperitoneal injection of naphthalene (1.5 mmol/kg) were treated with either prodrug (2.5 mmol/kg) 30 min later. Both compounds effectively maintained glutathione levels and decreased naphthalene-protein adducts in the lung and liver. However, cysteine-glutathione mixed disulfide was more effective at preventing Clara cell injury. To study the prodrugs in Clara cells without the influence of hepatic naphthalene metabolism and circulating glutathione, dose-response and time-course studies were conducted with intrapulmonary airway explant cultures. Only the ester of glutathione raised GSH in vitro; however, both compounds limited protein adducts and cell necrosis. In vitro protection was not associated with decreased naphthalene metabolism. We conclude that (1) glutathione prodrugs can prevent naphthalene toxicity in Clara cells, (2) the prodrugs effectively prevent glutathione loss in vivo, and (3) cysteine-glutathione mixed disulfide prevents naphthalene injury in vitro without raising glutathione levels.


Subject(s)
Glutathione/metabolism , Lung/drug effects , Lung/pathology , Naphthalenes/antagonists & inhibitors , Naphthalenes/toxicity , Prodrugs/pharmacology , Animals , Chromatography, High Pressure Liquid , Electrochemistry , Epithelium/drug effects , Lung/metabolism , Male , Mice , Prodrugs/metabolism , Solubility , Water
5.
Clin Exp Allergy ; 34(10): 1627-33, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15479280

ABSTRACT

BACKGROUND: Airway smooth muscle hypertrophy is closely associated with the pathophysiology of hyper-reactive airways in allergic asthma. OBJECTIVE: To determine whether repeated exposure to allergens during postnatal lung development promotes remodelling of airway smooth muscle. METHODS: Infant, male rhesus monkeys (30-day-old) were sensitized to house dust mite allergen (HDMA) and then exposed to HDMA aerosol periodically over 5 months. Smooth muscle mass and bundle size and abundance in conducting airways were measured and compared with age-matched control (filtered air-exposed) monkeys. RESULTS: Total smooth muscle mass and average bundle size were significantly greater in the conducting airways of monkeys exposed to HDMA. Smooth muscle bundle abundance was not affected by exposure to HDMA. CONCLUSION: Repeated cycles of allergen exposure alter postnatal morphogenesis of smooth muscle, affecting both total mass and bundle size, in conducting airways of infant monkeys.


Subject(s)
Allergens/immunology , Antigens, Dermatophagoides/immunology , Asthma/immunology , Muscle, Smooth/immunology , Respiratory Muscles/immunology , Animals , Dermatophagoides farinae/immunology , Hypertrophy/immunology , Macaca mulatta , Male , Microscopy, Confocal/methods , Muscle, Smooth/growth & development , Muscle, Smooth/pathology , Respiratory Muscles/growth & development , Respiratory Muscles/pathology
6.
Toxicol Sci ; 82(1): 268-78, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15319489

ABSTRACT

Naphthalene (NA) is metabolized to highly reactive intermediates that are primarily detoxified by conjugation to glutathione (GSH). Intraperitoneal administration of naphthalene causes substantial loss of both hepatic and respiratory GSH, yet only respiratory tissues are injured in mice. The liver supplies GSH to other organs via the circulation, making it unclear whether respiratory GSH losses reflect in situ respiratory depletion or decreased hepatic supply. To address this concern, mice were exposed to naphthalene by inhalation (1.5-15 ppm; 2-4 h), thereby bypassing first-pass hepatic involvement. GSH levels and histopathology were monitored during the first 24 h after exposure. Half of the mice were given the GSH depletor diethylmaleate (DEM) 1 hour before naphthalene exposure. Lung and nasal GSH levels rapidly decreased (50-90%) in mice exposed to 15 ppm naphthalene, with cell necrosis throughout the respiratory tract becoming evident several hours later. Conversely, 1.5 ppm naphthalene caused moderate GSH loss and only injured the nasal olfactory epithelium. Neither naphthalene concentration depleted hepatic GSH. Animals pretreated with DEM showed significant GSH loss and injury in nasal and intrapulmonary airway epithelium at both naphthalene concentrations. DEM treatment, perhaps by causing significant GSH loss, decreased water-soluble naphthalene metabolite formation by 48% yet increased NA-protein adducts 193%. We conclude that (1) GSH depletion occurs in airways independent of hepatic function; (2) sufficient GSH is not supplied by the liver to maintain respiratory GSH pools, or to prevent injury from inhaled naphthalene; and (3) GSH loss precedes injury and increases protein adduct formation.


Subject(s)
Glutathione/metabolism , Naphthalenes/pharmacokinetics , Naphthalenes/toxicity , Respiratory Tract Diseases/chemically induced , Administration, Inhalation , Animals , Animals, Outbred Strains , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Drug Therapy, Combination , Inactivation, Metabolic , Liver/drug effects , Liver/metabolism , Lung/drug effects , Lung/metabolism , Lung/pathology , Male , Maleates/pharmacology , Mice , Naphthalenes/administration & dosage , Olfactory Mucosa/drug effects , Olfactory Mucosa/metabolism , Olfactory Mucosa/pathology , Respiratory Tract Diseases/metabolism , Respiratory Tract Diseases/pathology
7.
Clin Exp Allergy ; 34(7): 1131-6, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15248862

ABSTRACT

BACKGROUND: In previous studies, we showed that repeated exposure to (1) house dust mite allergen (HDMA) (Dermatophagoides farinae) caused thickening of the basement membrane zone (BMZ) and (2) HDMA+ozone (O3) caused depletion of BMZ perlecan and atypical development of BMZ collagen (irregular thin areas<2.0 microm in width). OBJECTIVE: The purpose of this study was to determine if these remodelling changes were reversible after 6 months of recovery. METHODS: Rhesus monkeys were exposed to a regimen of HDMA and or O3 or filtered air (FA) for 6 months. After the exposure protocol was completed FA and O3 groups were allowed to recover in FA for 6 months. The HDMA and HDMA+O3 exposure groups recovered in a modified environment. They were re-exposed to HDMA aerosol for 2 h at monthly intervals during recovery in order to maintain sensitization for pulmonary function testing. To detect structural changes in the BMZ, collagen I and perlecan immunoreactivity were measured and compared to data from the previous papers. RESULTS: The remodelled HDMA group had a significantly thicker BMZ and after 6 months of recovery the width had not regressed. In the remodelled BMZ of the HDMA+O3 group, perlecan had returned to the BMZ after 6 months of the recovery protocol, and the thin, irregular, collagen BMZ had been resolved. CONCLUSION: In summary, this study has shown that: (1) The width of the remodelled HDMA BMZ did not regress during a recovery protocol that included a sensitizing dose of HDMA. (2) The atypical collagen BMZ in the HDMA+O3 BMZ was resolved in the absence of O3. (3) Depletion of perlecan from the BMZ by O3 was reversed by recovery in the absence of O3.


Subject(s)
Antigens, Dermatophagoides/pharmacology , Basement Membrane/chemistry , Dermatophagoides farinae , Hypersensitivity/metabolism , Trachea/metabolism , Animals , Basement Membrane/immunology , Basement Membrane/pathology , Collagen Type I/analysis , Heparan Sulfate Proteoglycans/analysis , Hypersensitivity/immunology , Hypersensitivity/pathology , Immunohistochemistry/methods , Macaca mulatta , Microscopy, Fluorescence , Ozone/pharmacology , Time Factors
8.
Clin Exp Allergy ; 33(12): 1686-94, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14656356

ABSTRACT

BACKGROUND: The effect of chronic environmental aeroallergen exposure on the immune system and airways has not been experimentally defined in very young children. OBJECTIVE: The purpose of this study was to determine the immunophenotype of peripheral blood and airway leucocytes in the newborn rhesus macaque monkey, following recurrent aerosol exposure to house dust mite (HDM) (Dermatophagoides farinae). METHODS: A regimen of HDM aerosolization was initiated for 2 h per day, three times per week, starting when rhesus macaque monkeys were 1 week of age. All monkeys were inoculated with diptheria, tetanus, and acellular pertussis vaccine at 5 weeks of age to simulate human infant vaccination schedules. RESULTS: Following 8 weeks of HDM aeroallergen exposure, infant monkeys exhibited a significant reduction in the total peripheral blood lymphocyte numbers and a decreased frequency of peripheral blood CD4+ T lymphocytes with a CD45RA-'memory' immunophenotype. Lavage CD4+ T lymphocytes from HDM-exposed monkeys showed elevated expression of CD25, as well as an increase in CD45RA-/CD62L-/CD11ahigh immunophenotype. Eosinophils were more abundant within airways of HDM-exposed monkeys, accumulating maximally within the trachea. CONCLUSION: These data demonstrate the development of immunological responses following chronic inhalation of a common environmental allergen during postnatal maturation in the non-human primate.


Subject(s)
Animals, Newborn/immunology , Antigens, Dermatophagoides/administration & dosage , CD4-Positive T-Lymphocytes/immunology , Dermatophagoides farinae/immunology , Environmental Exposure , Animals , CD11a Antigen/analysis , Eosinophils/immunology , Flow Cytometry , Immunologic Memory , L-Selectin/analysis , Leukocyte Common Antigens/analysis , Lung/immunology , Lymphocyte Count , Macaca mulatta , Male , Models, Animal , Receptors, Interleukin-2/analysis
9.
Eur Respir J ; 22(2): 374-82, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12952276

ABSTRACT

In vivo animal models can offer valuable information on several aspects of asthma pathogenesis and treatment. The mouse is increasingly used in these models, mainly because this species allows for the application in vivo of a broad range of immunological tools, including gene deletion technology. Mice, therefore, seem particularly useful to further elucidate factors influencing the response to inhaled allergens. Examples include: the role of immunoregulatory mechanisms that protect against T-helper cell type 2 cell development; the trafficking of T-cells; and the contribution of the innate immunity. However, as for other animal species, murine models also have limitations. Mice do not spontaneously develop asthma and no model mimics the entire asthma phenotype. Instead, mice should be used to model specific traits of the human disease. The present task force report draws attention to specific aspects of lung structure and function that need to be borne in mind when developing such models and interpreting the results. In particular, efforts should be made to develop models that mimic the lung function changes characteristic of asthma as closely as possible. A large section of this report is therefore devoted to an overview of airway function and its measurement in mice.


Subject(s)
Asthma/pathology , Asthma/physiopathology , Disease Models, Animal , Animals , Asthma/immunology , Humans , Lung/immunology , Lung/pathology , Lung/physiopathology , Mice
10.
Drug Metab Rev ; 34(4): 791-820, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12487150

ABSTRACT

The lung, which is in intimate contact with the external environment, is exposed to a number of toxicants both by virtue of its large surface area and because it receives 100% of the cardiac output. Lung diseases are a major disease entity in the U.S. population ranking third in terms of morbidity and mortality. Despite the importance of these diseases, key issues remain to be resolved regarding the interactions of chemicals with lung tissue and the factors that are critical determinants of chemical-induced lung injury. The importance of cytochrome P450 monooxygenase dependent metabolism in chemical-induced lung injury in animal models was established over 25 years ago with the furan, 4-ipomeanol. Since then, the significance of biotransformation and the reasons for the high degree of pulmonary selectivity for a myriad of different chemicals has been well documented, mainly in rodent models. However, with many of these chemicals there are substantial differences in the susceptibility of rats vs. mice. Even within the same species, varied levels of the respiratory tract respond differently. Thus, key pieces of data are still missing when evaluating the applicability of data generated in rodents to primates, and as a result of this, there are substantial uncertainties within the regulatory community with regards to assessing the risks to humans for exposure to some of these chemicals. For example, all of the available data suggest that the levels of cytochrome P450 monooxygenases in rodent lungs are 10-100 times greater than those measured in the lungs of nonhuman primates or in man. At first glance, this suggests that a significant margin of safety exists when evaluating the applicability of rodent studies in the human, but the issues are more complex. The intent of this review is to outline some of the work conducted on the site and species selective toxicity and metabolism of the volatile lung toxic aromatic hydrocarbon, naphthalene. We argue that a complete understanding of the cellular and biochemical mechanisms by which this and other lung toxic compounds generate their effects in rodent models with subsequent measurement of these cellular and biochemical events in primate and human tissues in vitro will provide a far better basis for judging whether the results of studies done in rodent models are applicable to humans.


Subject(s)
Naphthalenes/toxicity , Respiratory System/drug effects , Respiratory System/metabolism , Animals , Cytochrome P-450 Enzyme System/metabolism , Humans , Naphthalenes/chemistry , Naphthalenes/metabolism , Respiratory System/injuries
11.
J Appl Physiol (1985) ; 93(4): 1506-14, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12235053

ABSTRACT

Airway smooth muscle remodeling is implicated in a number of constrictive pulmonary diseases such as asthma and may include changes in smooth muscle orientation and abundance. Both factors were compared in the normal distal bronchioles of the mouse, rabbit, and rhesus monkey (respiratory bronchioles included). Airway smooth muscle was measured by using a three-dimensional approach employing confocal microscopy and whole-mount cytochemistry with fluorochrome-conjugated phalloidin, a probe for polymerized actin. Smooth muscle orientation had a wide range of angles along the airway, but the distribution was conserved among species and among distal airway generations. At the bifurcation of proximal bronchioles, smooth muscle was nearly parallel to the longitudinal axis of the airway. Smooth muscle abundance was significantly different between species (abundance was less in the monkey compared with the mouse and rabbit), and there was a trend for abundance to decrease with each more distal airway generation. This study defines the normal distribution of smooth muscle in three test species and provides a basis for future comparisons with the diseased state.


Subject(s)
Bronchi/anatomy & histology , Muscle, Smooth/anatomy & histology , Animals , Fluorescent Dyes , Histocytochemistry , Imaging, Three-Dimensional , Macaca mulatta , Male , Mice , Microscopy, Confocal , Phalloidine , Rabbits
12.
Am J Physiol Lung Cell Mol Physiol ; 283(3): L510-7, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12169568

ABSTRACT

We propose that lung morphogenesis and repair are characterized by complex cell-cell interactions of endodermal and mesodermal origin, leading to (or returning back to) an alveolar structure that can effectively exchange gases between the circulation and the alveolar space. We provide the developmental basis for cell/molecular control of lung development and disease, what is known about growth and transcription factors in normal and abnormal lung development, and how endodermal and mesodermal cell origins interact during lung development and disease. The global mechanisms that mediate mesenchymal-epithelial interactions and the plasticity of mesenchymal cells in normal lung development and remodeling provide a functional genomic model that may bring these concepts closer together. We present a synopsis followed by a vertical integration of the developmental and injury/repair mechanisms.


Subject(s)
Aging/physiology , Lung/embryology , Lung/growth & development , Mesoderm/physiology , Wound Healing/physiology , Animals , Bronchopulmonary Dysplasia/etiology , Embryo, Mammalian/physiology , Embryonic and Fetal Development , Epithelium/physiology , Fibroblasts/physiology , Humans , Infant, Newborn , Muscle, Smooth/cytology , Muscle, Smooth/physiology , Transcription Factors/physiology
13.
Mol Ther ; 4(6): 614-21, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11735346

ABSTRACT

We previously reported the efficiency of gene transfer in fetal monkeys using retroviral vectors and an intraperitoneal (IP) approach. Here, we explored intrapulmonary administration to determine whether gene transfer can be limited to the developing lung. The HIV-1-derived lentiviral vector (VSV-G pseudotyped; 1 x 10(7) infectious particles/fetus), using the enhanced green fluorescent protein (EGFP) as a reporter, was directly injected into fetal lung with ultrasound guidance (n=4; 55 or 70 days gestation; term 165+/-10 days). Fetuses were monitored sonographically, fetal/maternal blood samples collected during gestation, and four of four healthy newborns were delivered at term. All lung lobes were positive for the transgene (< or = 1%) when assessed by PCR, and transgene expression was observed by direct fluorescence microscopy and flow cytometry. The results of this study show the following: (1) successful gene transfer in fetal monkeys using an intrapulmonary approach; (2) less transduction of non-pulmonary tissues with gene transfer at 70 days gestation compared with 55 days gestation or use of an IP approach; (3) that the pulmonary epithelium was EGFP-positive by immunohistochemistry; and (4) no evidence of transplacental transport of vector sequences or antibody responses in the dams. The results of these investigations indicate the efficiency of fetal gene transfer by intrapulmonary delivery, and emphasize the importance of the fetal monkey as a preclinical model system for exploring in utero genetic treatment strategies for pulmonary disorders.


Subject(s)
HIV-1/genetics , Lung/embryology , Lung/metabolism , Macaca mulatta/embryology , Animals , DNA Primers/chemistry , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Gene Transfer Techniques , Genetic Therapy/methods , Genetic Vectors , Green Fluorescent Proteins , Hematopoietic Stem Cells/physiology , Humans , Immunoenzyme Techniques , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Macaca mulatta/genetics , Polymerase Chain Reaction , Promoter Regions, Genetic
14.
Am J Respir Cell Mol Biol ; 25(4): 434-8, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11694448

ABSTRACT

Leukotoxin is clinically associated with acute respiratory distress syndrome (ARDS). Recently, we found that leukotoxin-diol, the hydrated product of leukotoxin, is more toxic than the parent leukotoxin in vitro (Moghaddam and colleagues, Nature Med. 1997;3:562-566). To test if this difference in the toxicity of leukotoxin and leukotoxin-diol exists in vivo, Swiss Webster mice were administered leukotoxin or leukotoxin-diol. All mice treated with leukotoxin-diol died of ARDS-like respiratory distress, whereas the animals exposed to leukotoxin at the same dose survived. Histopathologic evaluation of the lungs revealed massive alveolar edema and hemorrhage with interstitial edema around blood vessels in the lungs of mice treated with leukotoxin-diol, whereas the lungs of mice treated with identical doses of leukotoxin had perivascular edema only and little change in alveolar spaces. Immunohistochemistry showed that the soluble epoxide hydrolase responsible for the hydrolysis of leukotoxin to its diol is concentrated in the vascular smooth muscle of small and medium-sized pulmonary vessels. In addition, 4-phenylchalcone oxide, an inhibitor of soluble epoxide hydrolase, was found to decrease the mortality induced by leukotoxin but had no effect on mortality induced by leukotoxin-diol. These studies provide strong in vivo evidence that leukotoxin may act as a protoxicant and that the corresponding diol is a putative toxic mediator involved in the development of ARDS.


Subject(s)
Chalcone/analogs & derivatives , Respiratory Distress Syndrome/chemically induced , Stearic Acids/toxicity , Animals , Chalcone/pharmacology , Chalcones , Dose-Response Relationship, Drug , Edema/chemically induced , Enzyme Inhibitors/pharmacology , Epoxide Hydrolases/antagonists & inhibitors , Epoxide Hydrolases/drug effects , Epoxide Hydrolases/metabolism , Exotoxins/toxicity , Lung/drug effects , Lung/pathology , Male , Mice , Respiratory Distress Syndrome/mortality , Respiratory Distress Syndrome/pathology
15.
J Allergy Clin Immunol ; 108(4): 557-62, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11590381

ABSTRACT

BACKGROUND: Extended exposure to allergen exacerbates asthma symptoms, in part via complex interactions between inflammatory cells and mediators. One consequence of these interactions is the triggering of local and central nervous system (CNS) neuronal activity that might further exacerbate the asthma-like symptoms by causing bronchoconstriction, mucous secretion, increased microvascular leak, and cough. One CNS region that might be particularly important is the caudomedial nucleus tractus solitarius (NTS). NTS neurons not only integrate primary afferent inputs from lung sensory nerve fibers but also have direct exposure to inhaled allergens and allergen-induced blood-borne inflammatory mediators via a deficient blood-brain barrier. Given the capacity of CNS neurons to undergo plasticity, allergen-induced changes in NTS neuronal properties could contribute to the exaggerated respiratory responses to extended allergen exposure. OBJECTIVE: In a recently developed rhesus monkey model of allergic asthma, we tested the hypothesis that extended exposure to allergen increases the intrinsic excitability of NTS neurons. METHODS: Three adult monkeys were sensitized and then repeatedly exposed to aerosols of house dust mite allergen; 4 monkeys served as controls. Whole-cell current-clamp recordings were made to measure 3 indices of excitability: resting membrane potential, input resistance, and number of action potentials evoked by current injections. RESULTS: Extended allergen exposure depolarized the resting membrane potential by 14% and increased the number of action potentials evoked by current injections (5-fold). CONCLUSION: The finding that NTS neurons in a primate model of allergic asthma undergo intrinsic increases in excitability suggests that CNS mechanisms might contribute to the exaggerated symptoms in asthmatic individuals exposed to allergen.


Subject(s)
Allergens/adverse effects , Asthma/etiology , Neuronal Plasticity/physiology , Solitary Nucleus/physiology , Animals , Electric Conductivity , Environmental Exposure , Female , In Vitro Techniques , Macaca mulatta , Male , Mites/immunology , Patch-Clamp Techniques
16.
Obstet Gynecol ; 98(3): 466-70, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11530131

ABSTRACT

OBJECTIVE: To compare direct intra-amniotic injection of betamethasone and thyroxine (T4) with maternal treatment and controls for accelerating pulmonary surfactant production. METHODS: Twelve pregnant monkeys (Macaca mulatta) on gestational day 125 (term 165 +/- 10 days) had surfactant protein A and B concentrations measured in amniotic fluid. In four controls, normal saline was injected into the amniotic fluid; four others (intra-amniotic) received intra-amniotic betamethasone (1 mg) and T4 (60 microg); and in four others (maternal), the dam was given betamethasone (12 mg) intramuscularly, repeated in 24 hours, plus TRH (400 microg) intravenously, repeated every 6 hours for 24 hours. Seventy-two hours after the initial amniocentesis, a hysterotomy was performed and fetal tissue and amniotic fluid harvested for determination of surfactant protein A and B concentrations and immunohistochemical staining for surfactant protein A. RESULTS: Amniotic fluid surfactant protein A was higher with intra-amniotic injection than with maternal treatment (P <.04) or controls (P =.07). Amniotic fluid surfactant protein B was higher in the intra-amniotic group than in controls (P =.06). Immunohistochemical staining for surfactant protein A in the lung tissue was increased in the intra-amniotic group compared with controls (0.145 +/- 0.01 versus 0.097 +/- 0.001, percent positive staining for surfactant protein A cells per lung tissue cells; P <.03). Birth weight was greater in the intra-amniotic group compared with the maternal group (P <.03) although not different from the controls. Finally, gut motility and the presence of formed meconium were increased in the intra-amniotic group compared with the other groups (P <.05). CONCLUSION: Intra-amniotic injection of betamethasone and T4 enhanced lung (and possibly intestinal) maturation of the preterm rhesus fetal monkey compared with maternal injections.


Subject(s)
Amniotic Fluid/chemistry , Betamethasone/pharmacology , Glycoproteins/biosynthesis , Protein Precursors/biosynthesis , Proteolipids/biosynthesis , Pulmonary Surfactants/biosynthesis , Thyroxine/pharmacology , Animals , Betamethasone/administration & dosage , Female , Immunohistochemistry , Injections , Macaca mulatta , Pregnancy , Pulmonary Surfactant-Associated Proteins , Thyroxine/administration & dosage
17.
Exp Lung Res ; 27(5): 401-15, 2001.
Article in English | MEDLINE | ID: mdl-11480582

ABSTRACT

Basal cells exist as a separate layer of cells covering most of the airway basal lamina. In this central position, they can interact with columnar epithelium, neurons, basement membrane, and the underlying mesenchymal cells. In addition, they interact with inflammatory cells, lymphocytes and dendritic cells. These interactions take place in the lateral intercellular space between basal cells. In this central position basal cells become a very important part of the epithelial-mesenchymal trophic unit of larger airways. In this review it is shown that basal cells may function as progenitor cells of airway epithelium and have a role in attachment of columnar epithelium with the basement membrane. They also have the potential to function in regulation of neurogenic inflammation, the inflammatory response, transepithelial water movement, oxidant defense of the tissue and formation of the lateral intercellular space. Other characteristics of basal cells were not clearly associated with a particular function. The functions for basal cells listed attempt to explain the presence of recently identified molecules in basal cells of airway epithelium. It should be pointed out that specific studies have not been carried out which test the relationship between the molecular functions we describe in this review and the basal cell in airway epithelium.


Subject(s)
Epithelial Cells/physiology , Trachea/cytology , Animals , Basement Membrane , Bronchi/cytology , Epithelial Cells/cytology , Epithelial Cells/metabolism , Humans
18.
Arch Biochem Biophys ; 392(1): 32-7, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11469791

ABSTRACT

Leukotoxin, a cytochrome P450-derived epoxide of linoleic acid, has been implicated as a causative factor in acute respiratory distress syndrome. Conversion of this fatty acid epoxide to leukotoxin diol by epoxide hydrolase has been hypothesized as the critical activation step in leukotoxin-induced cellular toxicity. In both human and insect cells, we observed that leukotoxin diol causes acute cellular toxicity and that cyclosporin A, an inhibitor of the mitochondrial permeability transition, ameliorates leukotoxin diol-associated toxicity. To evaluate mitochondria as a target of leukotoxin diol, multiple aspects of mitochondrial integrity were evaluated in both cell- and organelle-based assays. Leukotoxin diol specifically activated the mitochondrial permeability transition, resulting in release of cytochrome c and subsequent cell death. Pretreatment with cyclosporin A inhibited these effects and, furthermore, limited in vivo toxicity. While the mechanisms underlying leukotoxin-mediated toxicity remain to be fully elucidated, the observation that leukotoxin diol disrupts mitochondrial function specifically through activation of the mitochondrial permeability transition suggests at least one mechanism through which leukotoxin diol may exert its activity in physiological contexts.


Subject(s)
Mitochondria/drug effects , Mitochondria/metabolism , Stearic Acids/toxicity , Animals , Cell Death/drug effects , Cell Line , Cyclosporine/pharmacology , HeLa Cells , Humans , In Vitro Techniques , Intracellular Membranes/drug effects , Intracellular Membranes/metabolism , Lung/drug effects , Lung/metabolism , Lung/pathology , Male , Mice , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , Permeability/drug effects , Spodoptera
19.
Toxicol Appl Pharmacol ; 173(2): 114-9, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11384213

ABSTRACT

Current OSHA standards for naphthalene exposure are set at 10 ppm (time-weighted average) with a standard threshold exposure concentration of 15 ppm. While several studies have thoroughly delineated the time course and dose response of injury by naphthalene administered ip, the pattern and severity of injury by inhalation exposure are unknown. These studies compare the regiospecific and dose-dependent cytotoxicity of naphthalene after inhalation exposure. Mice and rats were exposed for 4 h to naphthalene vapor at concentrations of 0-110 ppm. In rats, no injury was observed in the lung epithelium at exposure concentrations up to 100 ppm. Exposures as low as 2 ppm produced proximal airway injury in mice, with increased severity in a concentration-dependent fashion up to 75 ppm. Terminal airways of exposed mice exhibited little or no injury at low concentrations (1-3 ppm). Exposures of 8.5 ppm or higher were required to produce injury to Clara cells in the terminal airways. In contrast, administration of naphthalene (300 mg/kg) extended the injury pattern toward the lobar bronchus. We conclude (1) the pattern of injury to naphthalene is highly dependent on the route of exposure, (2) lung injury to inhaled naphthalene is species dependent, and (3) Clara cells of mouse airways are exquisitely sensitive to inhaled naphthalene at concentrations well below the current OSHA standard for human exposure.


Subject(s)
Lung/drug effects , Naphthalenes/toxicity , Respiratory Mucosa/drug effects , Administration, Inhalation , Air Pollutants/toxicity , Animals , Bronchi/drug effects , Bronchi/pathology , Dose-Response Relationship, Drug , Injections, Intraperitoneal , Lung/pathology , Male , Mice , Naphthalenes/administration & dosage , Rats , Rats, Sprague-Dawley , Respiratory Mucosa/pathology
20.
Toxicology ; 160(1-3): 173-80, 2001 Mar 07.
Article in English | MEDLINE | ID: mdl-11246137

ABSTRACT

As one of the principal interfaces between the organism and the environment, the respiratory system is a target for a wide variety of toxicants and carcinogens. The cellular and architectural complexity of the respiratory system appears to play a major role in defining the focal nature of the pulmonary response to environmental stressors. This review will address the biological factors that modulate the response of one of the major target compartments within the respiratory system, the tracheobronchial airway tree. Individual airway segments respond uniquely to toxic stress and this response involves not only the target cell population, e.g. epithelium, but also other components of the airway wall suggesting a trophic interaction within all components of the airway wall in maintaining steady state and responding to injury. A number of biological factors modulate the nature of the response, including: (1) metabolic potential at specific sites for activation and detoxification; (2) the nature of the local inflammatory response; (3) age of the organism at the time of exposure; (4) gender of the exposed organism; (5) history of previous exposure; and (6) species and strain of the organism exposed.


Subject(s)
Bronchi/drug effects , Respiratory Mucosa/drug effects , Trachea/drug effects , Xenobiotics/toxicity , Aging , Animals , Bronchi/metabolism , Drug Tolerance , Humans , Inactivation, Metabolic , Neutrophil Infiltration/drug effects , Respiratory Mucosa/metabolism , Sex Characteristics , Species Specificity , Trachea/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...